• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, INC. (AF-MINNETONKA) SWARTZ¿ BRAIDED TRANSSEPTAL GUIDING INTRODUCER, SL1¿, 63 CM LENGTH, 8.5F; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, INC. (AF-MINNETONKA) SWARTZ¿ BRAIDED TRANSSEPTAL GUIDING INTRODUCER, SL1¿, 63 CM LENGTH, 8.5F; INTRODUCER, CATHETER Back to Search Results
Model Number 407453
Device Problem Device Operates Differently Than Expected (2913)
Patient Problems Low Blood Pressure/ Hypotension (1914); Pericardial Effusion (3271)
Event Date 09/30/2014
Event Type  Injury  
Event Description
Related manufacturer reference 3005188751-2014-00127, 3005188751-2014-00128, 3005188751-2014-00129, 2030404-2014-00097.During an atrial fibrillation ablation procedure, a pericardial effusion occurred.Two transseptal punctures were completed using a brk needle and a swartz braided transseptal introducer.The introducer was exchanged with an agilis nxt introducer, through which a safire blu duo ablation catheter was advanced into the left atrium.A reflexion spiral ep catheter was also advanced into the left atrium.The patient became hypotensive and a pericardial effusion was noted via a non-sjm ice catheter.The procedure was stopped and a pericardiocentesis was performed, which stabilized the patient.Once the patient was stable, a cavotricuspid isthmus line ablation was performed.The patient remained stable and was transferred to the icu for observation.There were no performance issues with any sjm device.
 
Manufacturer Narrative
Additional information: the results of the investigation are inconclusive since the device was not returned for analysis.Our investigation was limited to the review of the device history record, which showed that each manufacturing and inspection operation was performed and indicated complete in accordance with sjm specifications and procedures.Based on the information received, the cause of the reported incident could not be conclusively determined.Per the ifu, cardiac perforation is a known risk during the use of this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SWARTZ¿ BRAIDED TRANSSEPTAL GUIDING INTRODUCER, SL1¿, 63 CM LENGTH, 8.5F
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
ST. JUDE MEDICAL, INC. (AF-MINNETONKA)
14901 deveau place
minnetonka MN 55345
Manufacturer (Section G)
ST. JUDE MEDICAL, INC.
14901 deveau place
minnetonka MN 55345
Manufacturer Contact
denise johnson
5050 nathan lane north
plymouth, MN 55442
6517564470
MDR Report Key4197483
MDR Text Key5147341
Report Number3005188751-2014-00130
Device Sequence Number1
Product Code DYB
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
PK052644
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/30/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/23/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/31/2017
Device Model Number407453
Device Lot Number4621174
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/08/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/10/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
BRK TRANSSEPTAL NEEDLE; REFLEXION SPIRAL EP CATHETER; AGILIS NXT INTRODUCER; SAFIRE BLU DUO ABLATION CATHETER
Patient Outcome(s) Required Intervention;
Patient Age64 YR
Patient Weight100
-
-